# Rolin L. Wade

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rolin-l-wade/

## Facts

| Field | Value |
| --- | --- |
| Citations | 897 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 17 |
| i10-index | 29 |
| Last Known Institution | IQVIA (United States) |
| OpenAlex ID | https://openalex.org/A5054726198 |
| ORCID iD | 0000-0003-3634-1504 |
| Works | 120 |

## Researcher papers

- [Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex](https://scholariq.org/papers/nephrotoxicity-and-other-adverse-events-among-inpatients-receiving-liposomal/)
- [Enzymes of drug metabolism during delirium](https://scholariq.org/papers/enzymes-of-drug-metabolism-during-delirium/)
- [Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors](https://scholariq.org/papers/treatment-patterns-and-patient-characteristics-among-early-initiators-of-pcsk9/)
- [<p>Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment</p>](https://scholariq.org/papers/and-lt-p-and-gt-treatment-adherence-and-persistence-among-hiv-1-patients-newly/)
- [Orphan Drug Expenditures In The United States: A Historical And Prospective Analysis, 2007–18](https://scholariq.org/papers/orphan-drug-expenditures-in-the-united-states-a-historical-and-prospective/)
- [Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib](https://scholariq.org/papers/real-world-treatment-patterns-time-to-next-treatment-and-economic-outcomes-in/)
- [Improving Medication Adherence and Health Care Outcomes in a Commercial Population through a Community Pharmacy](https://scholariq.org/papers/improving-medication-adherence-and-health-care-outcomes-in-a-commercial/)
- [Medication adherence, hospitalization, and healthcare resource utilization and costs in patients with pulmonary arterial hypertension treated with endothelin receptor antagonists or phosphodiesterase type‐5 inhibitors](https://scholariq.org/papers/medication-adherence-hospitalization-and-healthcare-resource-utilization-and/)
- [Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database](https://scholariq.org/papers/economic-and-clinical-burden-of-acute-myeloid-leukemia-episodes-of-care-in-the/)
- [Erenumab patient characteristics, medication adherence, and treatment patterns in the United States](https://scholariq.org/papers/erenumab-patient-characteristics-medication-adherence-and-treatment-patterns-in/)
- [US health care utilization and costs in adult patients with atopic dermatitis by disease severity](https://scholariq.org/papers/us-health-care-utilization-and-costs-in-adult-patients-with-atopic-dermatitis-by/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [IQVIA (United States)](https://scholariq.org/institutions/iqvia-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.